SLC7A5 and cholangiocarcinoma: However, there is no established explanation regarding the in vivo anti-tumor effect of LAT1 inhibitor, although there are two preclinical studies investigating the potential of LAT1 inhibitor in tumor xenografts (glioma [13] and cholangiocarcinoma [current study]).